James Murphy, Ph.D.
Dr. Murphy is Associate Professor, Department of Preventive Medicine & Biometrics, University of Colorado Health Sciences Center. He received his doctorate in Biostatistics from Johns Hopkins University. He has served as acting Chairman for the Department of Preventive Medicine & Biometrics at the University of Colorado. He has also been a AAAS Congressional Fellow in the Office of Senator Pete Domenici and a consultant to the National Research Council, the National Institute of Health and the Governor's Task Force on the Health Effects of the Rocky Flats Weapon Plant. He has co-authored papers on questionnaire and database design and data management.

Peter Kahn, Ph.D
Dr. Kahn is Associate Professor of Biochemistry at Rutgers University. A graduate of Harvard and Columbia University, he has also served as a visiting professor at the Universite Rene Descartes in Paris and as a visiting research scientist in the Department of Molecular Biophysics and Biochemistry at Yale University. Dr. Kahn has been Session Chair for the sixth, seventh, eighth and tenth international symposia on dioxins. He has also been appointed to the American Legion Scientific Advisory Committee and is a member of the New Jersey Cancer Commission Sub-committee on Environmental epidemiology. Dr. Kahn has been a principal investigator for research measuring dioxins and dibenzofurans in blood and tissue of Vietnam veterans as well as immunological markers.

Stuart Newman, Ph.D
Dr. Newman is Professor of Cell Biology and Anatomy, and Medicine, New York Medical College where he directs a developmental biology laboratory. He has served on advisory panels for the National Institutes of Health, and has testified before committees of both the Senate and House of Representatives on the hazards of cloning and genetic engineering. He has been a visiting research fellow at the Pasteur Institute, Paris, Monash University, Australia, the Indian Institute of Science, Bangalore, and the University of Tokyo. Dr. Newman has been awarded federal research grants for the study of limb development and cartilage differentiation. He is a Fellow of the Institute on Biotechnology and the Human Future, Chicago, IL.

JD Sherman, MD
Dr. Sherman is an adjunct professor, Dept. Sociology, Western Michigan Univ. Kalamazoo, MI. Dr. Sherman specializes in internal medicine, occupational medicine and toxicology. She has served as a clinical assistant professor at Wayne State University in Detroit. Prior to medical school, Dr. Sherman worked as a biologist and chemist for the Atomic Energy Commission, the U.S. Navy Radiological Defense Laboratory and Michigan State University. Dr. Sherman has been a consultant to NIOSH and to the EPA for the Toxic Substance Control Act and for the Office of Pesticides. She has also conducted research at the Pacific Biological Research Center at the University of Hawaii.

Wayland Swain, Ph.D
Dr. Swain received his doctorate in environmental biology and health from the University of Minnesota School of Public Health. He is a Fellow of the Royal Society of Health in London and is listed in American Men and Women of Sciences. He has served as Associate Professor and Head of the Department of Preventive Medicine at the University of Minnesota; Beatrix Crown Professor and Chairman of the Department of Aquatic Ecology at the University of Amsterdam; and Director of the Large Lakes Research Station, U.S.EPA, Grosse lle, Michigan. Dr. Swain is fluent in English, French, Spanish, German, Dutch, and Russian.